STOCK TITAN

Zoetis Named One of Newsweek’s Most Responsible Companies for 2022

Rhea-AI Impact
(No impact)
Rhea-AI Sentiment
(Very Positive)
Tags
  • Debuts at #71 (out of 500) in first year on Newsweek’s list
  • Only standalone animal health company included on the list
  • Ranked in the top 14% of all companies listed and the top 25% among Health Care & Life Sciences companies

PARSIPPANY, N.J.--(BUSINESS WIRE)-- Zoetis has been named to Newsweek Magazine's America's Most Responsible Companies 2022 list, which recognizes top-performing companies that are making a difference through their environmental, social and corporate governance actions. The company debuted at #71 (out of 500 companies) in its first year on the prestigious Newsweek list.

Zoetis is the only standalone animal health company and ranked in the top 14% of all companies listed and the top 25% among Health Care & Life Sciences companies on the list. In partnership with Statista Inc., Newsweek identified the top 500 most responsible companies from a pool of over 2,000 organizations across 14 industries, based on publicly available information as well as an independent study of 11,000 U.S. residents.

“Being recognized by Newsweek Magazine is a proud moment for Zoetis and affirms the way we strive to nurture the world and humankind by advancing animal care,” said Jeannette Ferran Astorga, Chief Sustainability Officer at Zoetis and President of the Zoetis Foundation. “This honor is a direct result of the work our colleagues do every day to drive a more sustainable future at Zoetis in how we run our business and support our customers and the animals in their care. As we continue our sustainability journey, we look forward to sharing more about how we are improving opportunities for veterinarians and livestock farmers through the Zoetis Foundation, developing innovative products that can help our customers raise healthier animals, and lessening our direct and indirect impact on our planet.”

In October, Zoetis was included in Investor’s Business Daily’s Top 100 ESG Companies. Earlier in the year, the company announced its Driven to Care long-term sustainability strategy and goals followed by its first Sustainability Report. Zoetis will continue to share updates on its sustainability activities, including progress against its Driven to Care goals, and report annually.

About Zoetis

As the world’s leading animal health company, Zoetis is driven by a singular purpose: to nurture our world and humankind by advancing care for animals. After nearly 70 years innovating ways to predict, prevent, detect, and treat animal illness, Zoetis continues to stand by those raising and caring for animals worldwide -- from livestock farmers to veterinarians and pet owners. The company’s leading portfolio and pipeline of medicines, vaccines, diagnostics and technologies make a difference in over 100 countries. A Fortune 500 company, Zoetis generated revenue of $6.7 billion in 2020 with approximately 11,300 employees. For more information, visit www.zoetis.com.

DISCLOSURE NOTICES

Forward-Looking Statements: This press release contains forward-looking statements, which reflect the current views of Zoetis with respect to: ESG commitments, goals and aspirations, the plans and future work of the Zoetis Foundation, and other future events. These statements are not guarantees of future performance or actions. Forward-looking statements are subject to risks and uncertainties. If one or more of these risks or uncertainties materialize, or if management's underlying assumptions prove to be incorrect, actual results may differ materially from those contemplated by a forward-looking statement. Forward-looking statements speak only as of the date on which they are made. Zoetis expressly disclaims any obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise. A further list and description of risks, uncertainties and other matters can be found in our Annual Report on Form 10-K for the fiscal year ended December 31, 2020, including in the sections thereof captioned “Forward-Looking Statements and Factors That May Affect Future Results” and “Item 1A. Risk Factors,” in our Quarterly Reports on Form 10-Q and in our Current Reports on Form 8-K. These filings and subsequent filings are available online at www.sec.gov, www.zoetis.com, or on request from Zoetis.

ZTS-COR
ZTS-IR

Media Contacts:

Christina Lood

1-973-822-7249 (o)

christina.lood@zoetis.com

Bill Price

1-973-443-2742 (o)

william.price@zoetis.com

Investor Contacts:

Steve Frank

1-973-822-7141 (o)

steve.frank@zoetis.com

Keith Gaub

1-973-822-7154 (o)

keith.gaub@zoetis.com

Source: Zoetis Inc.

Zoetis Inc

NYSE:ZTS

ZTS Rankings

ZTS Latest News

ZTS Stock Data

Pharmaceutical Preparation Manufacturing
Manufacturing
Link
Health Technology, Pharmaceuticals: Generic, Manufacturing, Pharmaceutical Preparation Manufacturing
US
Parsippany

About ZTS

Zoetis Inc. is an American drug company, the worlds largest producer of medicine and vaccinations for pets and livestock. The company was a subsidiary of Pfizer, the worlds largest drug maker, but with Pfizers spinoff of its 83% interest in the firm it is now a completely independent company.